Trial
NCT00195091
Phase II Study of Tetrathiomolybdate (TM) in Patients With Breast Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Memorial Sloan Kettering Cancer Center
Collaborators
Weill Medical College of Cornell University
Condition
Breast Cancer
Intervention
Tetrathiomolybdate
Why stopped
PI left MSKCC
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-05-16